Palbociclib from ABBEXA LTD

Search, find, compare suppliers for Palbociclib products.

Edit 
Product NamePalbociclib
DescriptionPalbociclib is a small molecule which can act as a CDK4 / CDK6 inhibitor. It is provided as a powder.

This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Autophagy, Glycation, Cell cycle, Senescence, Carbohydrate metabolism.
This product may be of interest in the following research areas and diseases: Immunology, Cell death, Cancer, Diabetes.
This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV in silico, probably through blocking the main protease, Mpro (3CLpro, Nsp5).

Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.

Solubility: 2 mg/ml in warm DMSO. Purity > 98% (TLC). Conforms to structure by NMR. MW: 447.5 g/mol
Size5 mg, 25 mg
Concentrationn/a
Applicationsn/a
Other NamesPalbociclib, Palbociclib (PD0332991), 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-piperazin-1-yl)pyridine-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one, PD-332991, 571190-30-2
Gene, Accession, CAS #CAS: 571190-30-2
Catalog #abx283096
Priceplease inquire
Order / More InfoPalbociclib from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.